Peroxisome proliferator-activated receptor γ agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity

• BAYLIS C

収録刊行物

• J Pharmacol Exp Ther

  J Pharmacol Exp Ther 307 854-860, 2003

詳細情報

• CRID: 1574231875337246720
• NII論文ID: 10021934871
• データソース種別:
  • CiNii Articles